These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 36153549)
1. An integrative bioinformatics investigation and experimental validation of critically involved genes in high-grade gliomas. Ahmadi-Beni R; Shahbazi S; Khoshnevisan A Diagn Pathol; 2022 Sep; 17(1):73. PubMed ID: 36153549 [TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data. Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134 [TBL] [Abstract][Full Text] [Related]
3. An integrated transcriptomic and computational analysis for biomarker identification in human glioma. Xing W; Zeng C Tumour Biol; 2016 Jun; 37(6):7185-92. PubMed ID: 26663173 [TBL] [Abstract][Full Text] [Related]
4. High CHI3L1 expression is associated with glioma patient survival. Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858 [TBL] [Abstract][Full Text] [Related]
5. PPIC, EMP3 and CHI3L1 Are Novel Prognostic Markers for High Grade Glioma. Gao YF; Zhu T; Mao CX; Liu ZX; Wang ZB; Mao XY; Li L; Yin JY; Zhou HH; Liu ZQ Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27801851 [TBL] [Abstract][Full Text] [Related]
6. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry. Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924 [TBL] [Abstract][Full Text] [Related]
7. Co-expression of mitosis-regulating genes contributes to malignant progression and prognosis in oligodendrogliomas. Liu Y; Hu H; Zhang C; Wang H; Zhang W; Wang Z; Li M; Zhang W; Zhou D; Jiang T Oncotarget; 2015 Nov; 6(35):38257-69. PubMed ID: 26468983 [TBL] [Abstract][Full Text] [Related]
8. Screening critical genes associated with malignant glioma using bioinformatics analysis. Xu Y; Wang J; Xu Y; Xiao H; Li J; Wang Z Mol Med Rep; 2017 Nov; 16(5):6580-6589. PubMed ID: 28901452 [TBL] [Abstract][Full Text] [Related]
9. Integrated analysis of genome-wide DNA methylation, gene expression and protein expression profiles in molecular subtypes of WHO II-IV gliomas. Wang ZL; Zhang CB; Cai JQ; Li QB; Wang Z; Jiang T J Exp Clin Cancer Res; 2015 Oct; 34():127. PubMed ID: 26502731 [TBL] [Abstract][Full Text] [Related]
10. DDX3X Biomarker Correlates with Poor Survival in Human Gliomas. Hueng DY; Tsai WC; Chiou HY; Feng SW; Lin C; Li YF; Huang LC; Lin MH Int J Mol Sci; 2015 Jul; 16(7):15578-91. PubMed ID: 26184164 [TBL] [Abstract][Full Text] [Related]
11. Identification of novel prognostic targets in glioblastoma using bioinformatics analysis. Yin X; Wu Q; Hao Z; Chen L Biomed Eng Online; 2022 Apr; 21(1):26. PubMed ID: 35436915 [TBL] [Abstract][Full Text] [Related]
12. Identification of Hub Gene GRIN1 Correlated with Histological Grade and Prognosis of Glioma by Weighted Gene Coexpression Network Analysis. Yang A; Wang X; Hu Y; Shang C; Hong Y Biomed Res Int; 2021; 2021():4542995. PubMed ID: 34840971 [TBL] [Abstract][Full Text] [Related]
13. Identification of genes related to low-grade glioma progression and prognosis based on integrated transcriptome analysis. Jiang Y; He J; Guo Y; Tao H; Pu F; Li Y J Cell Biochem; 2020 Jun; 121(5-6):3099-3111. PubMed ID: 31886582 [TBL] [Abstract][Full Text] [Related]
14. High miR-196a and low miR-367 cooperatively correlate with unfavorable prognosis of high-grade glioma. Guan Y; Chen L; Bao Y; Qiu B; Pang C; Cui R; Wang Y Int J Clin Exp Pathol; 2015; 8(6):6576-88. PubMed ID: 26261539 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of TELO2 decreases survival in human high-grade gliomas. Feng SW; Chen Y; Tsai WC; Chiou HC; Wu ST; Huang LC; Lin C; Hsieh CC; Yang YJ; Hueng DY Oncotarget; 2016 Jul; 7(29):46056-46066. PubMed ID: 27329594 [TBL] [Abstract][Full Text] [Related]
16. Bioinformatics analysis and experimental validation of TTK as a biomarker for prognosis in non-small cell lung cancer. Chen J; Wu R; Xuan Y; Jiang M; Zeng Y Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32969465 [TBL] [Abstract][Full Text] [Related]
17. Serine Incorporator 2 (SERINC2) Expression Predicts an Unfavorable Prognosis of Low-Grade Glioma (LGG): Evidence from Bioinformatics Analysis. Qi C; Lei L; Hu J; Wang G; Liu J; Ou S J Mol Neurosci; 2020 Oct; 70(10):1521-1532. PubMed ID: 32642801 [TBL] [Abstract][Full Text] [Related]
18. Shugosin 2 is a biomarker for pathological grading and survival prediction in patients with gliomas. Kao Y; Tsai WC; Chen SH; Hsu SY; Huang LC; Chang CJ; Huang SM; Hueng DY Sci Rep; 2021 Sep; 11(1):18541. PubMed ID: 34535705 [TBL] [Abstract][Full Text] [Related]
19. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis. Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001 [TBL] [Abstract][Full Text] [Related]
20. The promising novel biomarkers and candidate small molecule drugs in lower-grade glioma: Evidence from bioinformatics analysis of high-throughput data. Zhang B; Wu Q; Xu R; Hu X; Sun Y; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Wang Z; Zhou YL J Cell Biochem; 2019 Sep; 120(9):15106-15118. PubMed ID: 31020692 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]